Clinical Trial Update: Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing antiarrhythmic therapy versus catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Hypertrophic Cardiomyopathy

Snippet

Sponsor: National Institute of Cardiology, Warsaw, Poland | Conditions: Atrial Fibrillation, Hypertrophic Cardiomyopathy | Phase 3 | Status: COMPLETED